![](/images/Email.png)
TargetTyrosine-protein kinase JAK1 [866-1154](Homo sapiens (Human))
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
US Patent
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 5nMAssay Description:Enzyme inhibition studies were performed using recombinant JAK1 (amino acids 866-1154, Life Technologies, #PV4774, Carlsbad, Calif.), JAK2 (amino aci...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase JAK1 [866-1154](Homo sapiens (Human))
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
US Patent
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 5nMAssay Description:Enzyme inhibition studies were performed using recombinant JAK1 (amino acids 866-1154, Life Technologies, #PV4774, Carlsbad, Calif.), JAK2 (amino aci...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase JAK1 [866-1154](Homo sapiens (Human))
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
US Patent
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 5nMAssay Description:Enzyme inhibition studies were performed using recombinant JAK1 (amino acids 866-1154, Life Technologies, PV4774, Carlsbad, Calif.), JAK2 (amino acid...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)